By 2024, malignant neoplasms mortality among females in Japan is forecasted to increase gradually from 162.71 thousand deaths to 167.8 thousand by 2028. Between 2024 and 2028, the year-on-year mortality rates show a consistent increase of around 0.75% to 0.75% annually. The compound annual growth rate (CAGR) over this period is approximately 0.8%, indicating a steady rise in mortality from these conditions.

Future trends to watch for:

Advancements in early detection and treatment options which could impact mortality rates.
Influence of demographic shifts, such as aging population, on cancer prevalence.
Healthcare policy changes and public health initiatives aimed at cancer prevention.